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Increased concentrations of unconjugated bilirubin (UCB), namely its free fraction (Bf), in
neonatal life may cause transient or definitive injury to neurons and glial cells. We
demonstrated that UCB damages neurons and glial cells by compromising
oligodendrocyte maturation and myelination, and by activating astrocytes and
microglia. Immature neurons and astrocytes showed to be especially vulnerable.
However, whether microglia susceptibility to UCB is also age-related was never
investigated. We developed a microglia culture model in which cells at 2 days in vitro
(2DIV) revealed to behave as the neonatal microglia (amoeboid/reactive cells), in contrast
with those at 16DIV microglia that performed as aged cells (irresponsive/dormant cells).
Here, we aimed to unveil whether UCB-induced toxicity diverged from the young to the
long-cultured microglia. Cells were isolated from the cortical brain of 1- to 2-day-old CD1
mice and incubated for 24 h with 50/100 nM Bf levels, which were associated to moderate
and severe neonatal hyperbilirubinemia, respectively. These concentrations of Bf induced
early apoptosis and amoeboid shape in 2DIV microglia, while caused late apoptosis in
16DIV cells, without altering their morphology. CD11b staining increased in both, but more
markedly in 2DIV cells. Likewise, the gene expression of HMGB1, a well-known alarmin,
as well as HMGB1 and GLT-1–positive cells, were enhanced as compared to long-
maturated microglia. The CX3CR1 reduction in 2DIV microglia was opposed to the 16DIV
cells and suggests a preferential Bf-induced sickness response in younger cells. In
conformity, increased mitochondrial mass and NO were enhanced in 2DIV cells, but
unchanged or reduced, respectively, in the 16DIV microglia. However, 100 nM Bf caused
iNOS gene overexpression in 2DIV and 16DIV cells. While only arginase 1/IL-1b gene
expression levels increased upon 50/100 nM Bf treatment in long-maturated microglia,
MHCII/arginase 1/TNF-a/IL-1b/IL-6 (>10-fold) were upregulated in the 2DIV microglia.
Remarkably, enhanced inflammatory-associated microRNAs (miR-155/miR-125b/miR-
21/miR-146a) and reduced anti-inflammatory miR-124 were found in young microglia by
both Bf concentrations, while remained unchanged (miR/21/miR-125b) or decreased
(miR-155/miR-146a/miR-124) in aged cells. Altogether, these findings support the
neurodevelopmental susceptibilities to UCB-induced neurotoxicity, the most severein.org July 2020 | Volume 11 | Article 10121
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Neonatal hyperbilirubinemia, or jaundice, is a common condition of
the newborn, which may cause injury to neurons and glial cells, like
microglia, due to increased levels of unconjugated bilirubin (UCB)
(Brites, 2012). Neurological damage is produced by a small fraction
of UCB that is not bound to albumin (free bilirubin, Bf) and cross
the blood-brain barrier (Vodret et al., 2015). However, the
molecular mechanisms of bilirubin-induced neurological
dysfunction (BIND) and the determinants of cellular vulnerability
and reversibility are still only partially clarified, namely those
associated with microglia activation and dysfunction. The
susceptibility of neonates to BIND is also far from being
understood. In our previous studies we showed that immature
neurons and astrocytes are more vulnerable than older ones, and
that young astrocytes produce a larger amount of inflammatory
cytokines (Falcão et al., 2005; Falcão et al., 2006). The effects
produced are related with the nervous cell type and the intrinsic
signaling pathways involved. For instance, neurons revealed to be
highly vulnerable to UCB-induced cell death, while glial cells are
more involved in glutamate release and neuroinflammatory-
associated alterations (Brites, 2012).
Studies on microglia dysfunction and response to elevated
concentrations of UCB and Bf, aside ours, are practically non-
existent. We were the first to demonstrate that UCB activates and
damages microglial cells (Gordo et al., 2006; Silva et al., 2010).
UCB caused the switch from the ramified morphology into an
amoeboid shape, first inducing phagocytosis and later on the
release of inflammatory cytokines and glutamate that culminated
in cell death by apoptosis and necrosis. Last evidences
demonstrated that neuroinflammation is a key factor of BIND
and neuro-behavioral abnormalities in a mouse model of severe
neonatal hyperbilirubinemia (Vodret et al., 2018), and that
exosomes from the cerebrospinal fluid of full-term newborns
with acute bilirubin encephalopathy contain immune-
inflammatory associated proteins (Tan et al., 2020).
Microglia are the main neuroimmune cells that provide
neuroprotection by constantly surveying and sensing changes
within the brain, by clearing dying neurons and pathogens, and
by exerting immunoregulation. To fulfill these complex and
multivariate tasks, microglia adopt distinct phenotypes (Hickman
et al., 2018). Their functions are very important during the
neurodevelopment period, by participating in neurogenesis and
synaptic pruning programs (Cowan and Petri, 2018). It is nowadays
accepted that microglia activation occurs in a continuum way and
involves changes in gene expression and metabolism, cellular
morphology, motility, migration, phagocytosis, proliferation, and
ultimately death, as well as variations in cell-derived secretome
(Prinz et al., 2019).in.org 2Recently, it was shown that the secretome from phagocytic
microglia restricts neurogenesis, modulating the balance between
proliferation and survival, at least in the neurogenic niche (Diaz-
Aparicio et al., 2020). In addition, it was shown that the secretome
from the anti-inflammatory microglia increase the survival and
migration of neural stem cells, while restrains astrocyte
differentiation, as compared with the pro-inflammatory
phenotype (Osman et al., 2019). Upon activation, microglia
release a variety of toxic and proinflammatory mediators, such
as reactive oxygen and nitrogen species, cytokines, alarmins and
inflammatory-associated microRNAs (inflamma-miRs) (Brites
and Vaz, 2014; Sochocka et al., 2017; Guo et al., 2019; Brites,
2020). In such conditions, microglia can present multiple
activation phenotypes that may co-exist due to their plasticity
(Stratoulias et al., 2019). In the steady-state, the surveilling
microglia express the CX3C chemokine receptor 1 (CX3CR1)
for the neuronal fractalkine (CX3CL1) (Sheridan and Murphy,
2013), an axis with important role in the communication between
neurons and microglia, as well as in the modulation of
neuroinflammation (Corona et al., 2010; Thome et al., 2015; Bar
and Barak, 2019). CX3CR1 relevance was also demonstrated in
the synaptic refinement and transmission in the developing
hippocampus (Paolicelli et al., 2011). Microglia activation also
results from the stimulus of damaged-associated molecular
pattern (DAMP) alarmins that are released from dying cells and
stimulate the innate immune system (Gulke et al., 2018). One of
the most important is the high mobility group box 1 (HMGB1)
that, similarly to pro-inflammatory cytokines, interacts with Toll-
like receptors (TLRs), among others, inducing the transcription of
inflammatory mediators. HMGB1 by activating the NOD-like
receptor family pyrin domain containing 3 (NLRP3)
inflammasome (Chi et al., 2015) promotes the maturation and
release of interleukin (IL)-1b by the activation of caspase-1
(Walsh et al., 2014).
Inflamma-miRs have a critical function in inducing microglia
polarization and once in the microglia secretome have a
paracrine impact on the modulation of other cell types
(Alexander et al., 2015; Fernandes et al., 2018; Vaz et al., 2019;
Brites, 2020). From the several inflamma-miRs, miR-155 and
miR-125b usually associate with a pro-inflammatory phenotype,
miR-124 with immunoregulation (Ponomarev et al., 2011; He
et al., 2014), and miR-146a and miR-21 with anti-inflammatory
effects and cellular senescence (Bu et al., 2017). Expression of
inflamma-miRs by microglia were found to be age-dependent
(Burgess et al., 2015; Huan et al., 2018). We showed that
microglia isolated from the brain cortex of 2 day-old mice and
kept for short- and long-term cultures, switch from an activated/
reactive to senescent-like phenotypes (Caldeira et al., 2014).
Increased BIND in the neonatal period may relate with aJuly 2020 | Volume 11 | Article 1012
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a topic that was never investigated.
Bf neurotoxicity has been related with concentrations near or
modestly above its aqueous solubility of 70 nM (Ostrow et al.,
2003). Actually, Bf levels below 70 nM were shown to protect
neuronal cells from oxidative damage (Barañano et al., 2002;
Sedlak et al., 2009). However, we reported that concentrations of
100 and even 10 nM Bf may cause oxidative stress and injury to
neocortical synaptosomes after 4 h of incubation (Brito et al.,
2004). Recently, 24 h and 48 h treatment with 70 nM and 140 nM
Bf compromised the cell viability of SH-SY5Y human cells and
the highest concentration caused oxidative stress and DNA
damage (Rawat et al., 2018). Such protective and neurotoxic
distinct effects may associate to different cell types and culture
models used by the researchers.
Having all the above comments in mind, in this study we
evaluated how young and long-maturated mouse cortical
microglia are activated/injured by Bf concentrations of 50 nM
(below the limit of 70 nM) and 100 nM (slightly above the
aqueous solubility), after 24 h culture. For that, we used our
established primary microglial cell culture model to obtain cells
with 2 and 16 days in vitro (DIV) (Caldeira et al., 2014; Caldeira
et al., 2017). We examined microglia morphologies and markers of
oxidative stress, as well as the expression of the glutamate
transporter GLT-1, HMGB1, CX3CR1, and inflammatory-
associated mediators, including inflamma-miRs, in each
differently aged microglia treated with 50 and 100 mM Bf, to
better understand the role of microglia in the increased
susceptibilities of preterm and term neonates to UCB neurotoxicity.
Our data show that young (2DIV) microglia are more likely
activated, with increased number of amoeboid cells and HMGB1
positive cells than long-maturated (16DIV) ones. Overexpression
of GLT-1, inducible nitric oxide synthase (iNOS), inflammatory
cytokines, major histocompatibility complex II (MHCII),
arginase 1, and all inflamma-miRs, except miR-124, was the
result of both Bf concentrations in immature cells. On the other
hand, the long-maturated microglia were more irresponsive to
UCB-immunostimulation. These cells just showed increased
CX3CR1, depressed inflamma-miRs and upregulation of
arginase 1 and IL-1b, thus revealing a restrained inflammatory
phenotype upon interaction with Bf. Such understanding may
be important to define therapeutic interventions to recover
microglia neuroprotection in jaundiced neonates presenting
an increased risk of UCB encephalopathy.MATERIALS AND METHODS
Animals
This study was performed in accordance with the European
Community guidelines (Directives 86/609/EU and 2010/63/EU,
Recommendation 2007/526/CE, European Convention for the
Protection of Vertebrate Animals used for Experimental or Other
Scientific Purposes ETS 123/Appendix A) and Portuguese Laws on
Animal Care (Decreto-Lei 129/92, Portaria 1005/92, Portaria 466/
95, Decreto-Lei 197/96, Portaria 1131/97). All the protocols used in
this study were approved by the Portuguese National AuthorityFrontiers in Pharmacology | www.frontiersin.org 3(General Direction of Veterinary). Every effort was made to
minimize the number of animals used and their suffering.
Primary Culture of Microglia
Mixed glial cultures were prepared from 1- to 2-day-old CD1 mice
as usual in our lab (Caldeira et al., 2014). Briefly, cells (4 × 105 cells/
cm2) were plated in culture medium [DMEM-Ham’s F-12 medium
supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate,
non-essential amino acids, 10% fetal bovine serum (FBS), and 1%
antibiotic-antimycotic] and maintained at 37°C in a humidified
atmosphere of 5% CO2. After 21 days in mixed culture, microglia
were isolated by mild trypsinization according to the method of
Saura et al. (2003). This method resulted in the detachment of an
upper layer of cells containing astrocytes, whereas microglia
remained attached to the bottom of the well. The medium
containing detached cells was removed and the initial mixed glial-
conditioned medium was added. Culture medium was replaced
every 4 days and attached microglia were maintained in culture
until 2 or 16DIV, in order to have young and long-maturated cells,
respectively (Caldeira et al., 2014). Purity of microglia was nearly
100% in 2DIV cells and 98% in 16DIV cells, in which astrocytes
accounted for the 2% contamination when assessed by
immunocytochemical staining with a primary antibody against
glial fibrillary acidic protein (GFAP). Contamination by neurons
was null after staining with microtubule-associated protein 2
(MAP-2). Characterization of the 2DIV and 16DIV microglia was
previously described for nuclear factor kappa B (NF-kB) activation,
migration ability, phagocytic capacity, together with reactive and cell
senescence markers (Caldeira et al., 2014).
Cell Treatment
Microglia with 2DIV and 16DIV were incubated during 24 h, at
37°C, in the absence (control) or in the presence of 50 and 100
nM Bf which mimic the concentrations found in moderate and
severe neonatal jaundiced conditions, respectively. Such
concentrations were selected considering that the aqueous
saturation limit is 70 nM and that toxicity usually occurs at
Bf levels near or modestly above the aqueous solubility of
bilirubin (Ostrow et al., 2003). Stock Bf solutions were
extemporarily prepared in 0.1 N NaOH solution, immediately
before incubation and under light protection to prevent photo-
degradation. Value of pH was adjusted to 7.4 by adding 0.1 N
HCl. UCB was obtained from Sigma and purified as usual in
our lab (Vaz et al., 2011a).
Immunocytochemistry
We assessed microglia activation by evaluating cell morphology
with Iba1 and CD11b intensity/area by immunostaining. After
incubation, cells were fixed for 20 min with 4% (w/v)
paraformaldehyde and incubated with primary antibodies raised
against Iba1 (rabbit, 1:150, Wako) or Cd11b (rat, 1:100, Biolegend),
followed by species-specific secondary antibodies. For HMGB1, we
used the primary antibody against HMGB1 (mouse, 1:100,
Biolegend) followed by species-specific secondary antibody. In
this case, we counted the percentage of HMGB1-positive cells
above a certain threshold, considering the same background and
time of exposure when acquiring the image. We also evaluatedJuly 2020 | Volume 11 | Article 1012
Vaz et al. Young Microglia: A Risk to Bilirubin Toxicityglutamate transporter GLT-1 expression by immunocytochemistry.
Here, we used the primary antibody raised against GLT-1 (rabbit,
1:180, Abcam) followed by species-specific secondary antibody.
Data were expressed as fold change relatively to aged-matched
non-treated cells (control).
In all cases, cell nuclei were stained with Hoechst 33258 dye.
Fluorescence was visualized using a fluorescence microscope
(model AxioScope.A1) coupled with AxioCam HR (Zeiss). Ten
random fields were acquired per sample. Image analysis and
processing of the fluorescent-labelled cells were done using
ImageJ software, and individual microglia manually traced
with this software (Cunha et al., 2016).
Quantification of Nitrite Levels
Levels of nitric oxide (NO) were estimated by measuring the
concentration of nitrites (NO2-), a product of NO metabolism, in
the supernatants of microglial cells (Vaz et al., 2011a).
Extracellular media, free from cellular debris, was mixed with
Griess reagent [1% (w/v) sulfanilamide in 5% H3PO4 and 0.1%
(w/v) N-1 naphtylethylenediamine, from Sigma-Aldrich, in a
proportion of 1:1 (v/v)] in 96-well tissue culture plates for 10 min
in the dark, at room temperature. The absorbance was red at 540
nm using a microplate reader (Bio-Rad Laboratories, Hercules,
CA, USA) and a calibration curve used in each assay. Results
were expressed as fold change relatively to aged-matched non-
treated cells (control).
Mitochondria Fluorescence Intensity
The mitochondrial-related oxidative activity was detected by
Mitotracker® Red CMXRo (Invitrogen), a soluble dye that
permeates live cells in the not-fluorescent form and, once
inside the cells, is oxidized and converted into the fluorescent
form, thus staining active mitochondria (Barateiro et al., 2012).
After incubation, cells were incubated with 100 nM MitoTracker
dye, under light protection, for 30 min at room temperature.
Cells were then fixed for 20 min with paraformaldehyde 4% in
PBS. Cell nuclei were stained with Hoechst 33258 dye (1:1000)
and the relative fluorescence was visualized by fluorescence
microscope. Ten fields were captured randomly and analysed
by using the ImageJ software. The number of nuclei was counted
and the average MitoTracker intensity per cell calculated. Results
were then expressed as fold change relatively to aged-matched
non-treated cells (control).
Quantitative Real-Time PCR
Quantitative Real-Time (qRT)-PCR was performed as usual in our
lab (Vaz et al., 2019). Briefly, total RNA was extracted from
microglia using TRIzol® (LifeTechnologies), according to
manufacturer’s instructions. Total RNA was quantified using
Nanodrop ND-100 Spectrophotometer (NanoDrop Technologies)
and conversion to cDNAwas performed with GRS cDNA Synthesis
Master Mix (GRiSP, Porto, Portugal). qRT-PCR was performed on
a QuantStudio 7 Flex Real-Time PCR System (Applied Biosystems)
using an Xpert Fast Sybr Blue (GRiSP). qRT-PCRwas accomplished
under optimized conditions: 50°C for 2 min followed by 95°C for
2 min and finally 50 cycles at 95°C for 5 s and 62°C for 30 s. In order
to verify the specificity of the amplification, a melt-curve analysisFrontiers in Pharmacology | www.frontiersin.org 4was performed, immediately after the amplification protocol. Non-
specific products of PCR were not found in any case. Results were
normalized to b-actin and expressed as fold change. The sequences
used for primers are indicated in the Supplementary Table 1. For
miRNA analysis, conversion of cDNA was achieved with the
universal cDNA Synthesis Kit (#203301, Exiqon), following
manufacturer’s recommendations and as usual in our lab (Cunha
et al., 2016). The Power SYBR® Green PCR Master Mix (Applied
Biosystems) was used in combination with predesigned primers
(Exiqon), indicated in the Supplementary Table 1, using
SNORD110 as the reference gene. The reaction conditions
consisted of polymerase activation/denaturation and well-factor
determination at 95°C for 10 min, followed by 50 amplification
cycles at 95°C for 10 s and 60°C for 1 min (ramp-rate 1.6°/s).
Relative mRNA and miRNA concentrations were calculated using
theDDCT equation. All samples weremeasured in duplicate. Results
were expressed as fold change relatively to aged-matched non-
treated cells (control).
Determination of Cell Death
The rates of cell viability were obtained by Guava Nexin flow
cytometry (Guava easyCyte 5HT flow cytometer) that
differentiated three cell populations: viable cells (annexin V-PE
and 7-AAD negative), early-apoptotic cells (annexin V-PE
positive and 7-AAD negative) and late-apoptotic/necrotic cells
(annexin V-PE and 7-AAD positive). In brief, after incubation
with trypsin for 5 min at 37°C, the cells were collected and joined
to the incubation media. Then the samples were precipitated and
re-suspended in PBS (with BSA 1%). Guava Nexin® Reagent was
added to the samples during 20 min in darkness, following
manufacturer’s instructions and as usual in our lab (Gomes
et al., 2018).
Statistical Analysis
Results from at least three different independent experiments,
performed in duplicate, were expressed as mean ± SEM. For each
time in culture (2DIV or 16DIV), comparisons between non-
treated microglia (control) and Bf-treated (50 nM and 100 nM)
were performed by one-way ANOVA followed by multiple
comparisons Bonferroni post-hoc correction using GraphPad
Prism 7 (GraphPad Software, San Diego, CA, USA). P-values of
0.05 were considered statistically significant.RESULTS
Young Microglia Are Particularly
Susceptible to Bf-Induced Activation and
Sickness Response
We have previously demonstrated that cortical microglia isolated
from 1- to 2-day-old mice pups, maintained 21 days in mixed
culture with astrocytes, separated by mild trypsinization and
cultured for only 2DIV show a reactive phenotype (Caldeira et al.,
2014). However, such profile changed to a mature phenotype at
10DIV and to a less responsive and senescent-like microglia at
16DIV (e.g. reduced phagocytic and migration abilities, togetherJuly 2020 | Volume 11 | Article 1012
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miR-146a levels). Here, we evaluated how such age-differentiated
2DIV and 16DIV microglia react to 50 nM and 100 nM Bf,
considering that the first is below its aqueous saturation limit of
70 nM and the later above, with propensity to induce BIND
(Ostrow et al., 2003). These concentrations allowed us to use Bf
without the need of having albumin in the milieu, a condition that
better mimics the in vivo conditions once albumin is not present in
the brain, unless there is compromise of the blood-brain barrier.
Moreover, though previously indicated to prevent UCB-induced
toxicity towards neurons and astrocytes in mature and immature rat
hippocampal slices (Dani et al., 2019), albumin was also reported to
activate microglia and cause neurotoxicity (Hooper et al., 2009),
what could compromise the effects of Bf by itself.
We first assessed whether Bf was able to change microglia
viability. As indicated in Table 1, though no significant alterations
were produced in the number of viable cells, both Bf
concentrations increased the percentage of 2DIV cells suffering
early apoptosis (6 and 7% vs. 3% in controls) and that of 16DIV
presenting late apoptosis (between 8 and 9% vs. 3% in controls),
indicating different cell integrity compromise by Bf depending
from the time in culture. It should be noted, however, that in any
circumstance cell death relatively to controls surpassed the value of
10%, attesting the validity of the model to assess microglia
functional differences upon Bf treatment.
Microglia activation is usually associated with rounded/
amoeboid shapes, while the ramified morphology relates with
the surveillant state (Graeber, 2010). Bf-stimulation of
microglia morphological alterations after 24 h incubation was
assessed by immunofluorescent labelling against Iba1. While
the Bf-treated 16DIV cells remained ramified (almost 100%), an
increased number of amoeboid cells was observed in the 2DIV
microglia (Figure 1), supporting the acquisition of a more
activated/reactive stage (Domercq et al., 2013). To note that the
effects were similar with either 50 or 100 nM of Bf (p<0.05). We
hypothesize that such result derives from the soluble fraction
interacting with the microglia plasmatic membrane, i.e., the Bf
soluble species. Evaluation of CD11b immunostaining, a b-
integrin marker associated with microglial activation during
neurodegenerative inflammation (Roy et al., 2006), further
validated the preferential activation of 2DIV cells relatively to
16DIV microglia (Figure 2). As a proof of concept for the
increased reactivity in younger microglia, we evaluated theFrontiers in Pharmacology | www.frontiersin.org 5constitutive “calming” microglial signaling marker CX3CR1.
Indeed, CX3CR1 expression has been associated with a steady
state/surveilling microglia and linked to the neuronal CX3CL1
signaling in the healthy brain (Eyo and Wu, 2013). In Figure 3A,
it is evident that 100 nM Bf reduces the expression of CX3CR1 in
2DIV cells (p<0.05), which is consistent with the activated profile
previously observed in the young microglia. In contrast, CX3CR1
gene expression was induced by both Bf concentrations in 16DIV
cells, thus accounting for their supportive behavior when in the
presence of Bf.
The alarmin HMGB1 can be released under pathological
conditions and initiate inflammatory cascades. In our model, we
observed a marked elevation of HMGB1 gene expression in the
young cells exposed to Bf 50 nM and to 100 nM, while no
differences were found in the long-maturated cells (Figure 3B).
Since the effects of HMGB1 are dependent on complex
formation with different ligands that usually activate the
innate immune system and promote inflammation (Sha et al.,
2008; Youn et al., 2008), we additionally evaluated if the
localization of the HMGB1 protein was cytoplasmic or
nuclear, and quantified the number of HMGB1-positive cells
by immunofluorescence (above a common threshold). As
depicted in Figures 3C, D, HMGB1 was found present in
both nucleus and cytoplasm, with an increased number of
2DIV positive microglia upon interaction with 50 nM Bf
(p<0.05), relatively to the non-treated cells (control). In
contrast, 16DIV microglia behaved as non-responders to the
Bf stimulus.
To further explore the activation of 2DIV microglia by Bf, we
next explored the expression of GLT-1, since it was shown to be
highly expressed by activated microglia after facial nerve
axotomy (Lopez-Redondo et al., 2000), or subsequently to LPS
stimulation and tumor necrosis factor-alpha (TNF-a) increase
(Persson et al., 2005). Such upregulation of GLT-1 was suggested
to be a mechanism to prevent glutamate excitotoxicity (Lai et al.,
2013), which contributes to neuronal damage during
neuroinflammation (Barger et al., 2007). As expected, GLT-1
expression by immunocytochemistry was upregulated by both
concentrations of Bf in the 2DIV microglia (p<0.05), contrasting
with no changes in the long-maturated cells (Figure 4). These
results reinforce the ability of Bf to activate the young microglia
and indicate that the long-matured cells acquire resistance to the
immunostimulant effects of Bf.TABLE 1 | Percentage of viable, early apoptotic, and late apoptotic/necrotic microglia populations before and after treatment with free bilirubin concentrations.
2 DIV 16 DIV
Viable Early apoptosis Late apoptosis and necrosis Viable Early apoptosis Late apoptosis and necrosis
Control 91.3 ± 1.5 3.2 ± 0.4 3.8 ± 0.5 90.4 ± 1.6 3.8 ± 0.4 3.2 ± 0.2
Bf 50 nM 87.6 ± 1.0 6.6 ± 1.2* 6.5 ± 1.0 87.4 ± 0.7 3.9 ± 1.0 8.3 ± 1.3*
Bf 100 nM 88.6 ± 1.2 5.6 ± 0.7* 7.0 ± 1.2 86.5 ± 0.8 3.9 ± 0.6 8.8 ± 0.7*July 2Microglial cells were treated at 2 and 16 days-in-vitro (DIV) with free bilirubin (Bf) at 50 and 100 nM, during 24 h. After incubation, the percentage of viable, early apoptotic, and late-
apoptotic/necrotic cells were determined by flow cytometry with phycoerythrin-conjugated annexin V (annexinV-PE) and 7-amino-actinomycin D (7-AAD). The three populations were
distinguished as follows: viable cells (annexin V-PE and 7-AAD negative), early apoptotic cells (annexinV-PE positive and 7-AAD negative), and cells in late stages of apoptosis or necrosis
(annexinV-PE and 7-AAD positive). Results are mean± SEM from at least 3 independent experiments performed in duplicate. *p<0.05 vs. respective control.020 | Volume 11 | Article 1012
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FIGURE 2 | Expression of Cd11b increases in microglia after incubation with free bilirubin (Bf), though more notoriously in young 2DIV cells. Microglial cells were treated at 2
and 16 days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation, analysis of Cd11b intensity was performed by immunocytochemistry using anti-CD11b, as
indicated in methods. Representative results of one experiment are shown (A). Quantification of the fluorescence was performed by determining the mean fluorescence
intensity of each cell and normalized to their total area (B). For that, individual cells were manually traced using ImageJ software. Scale bar represents 40 mm. Results are
mean ± SEM from at least 3 independent experiments performed in duplicate. *p < 0.05 and **p < 0.01 vs. respective controls (untreated cells).A
B
FIGURE 1 | 2 DIV microglia develop an amoeboid morphology upon incubation with free bilirubin (Bf), an effect not produced in the 16 DIV aged cells. Microglial cells were
treated at 2 and 16 days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation, morphological analysis was performed by immunocytochemistry using anti-Iba1, as
indicated in methods. Representative results of one experiment are shown (A). Percentage of cells with ramified and amoeboid morphologies were quantified (B). Scale bar
represents 40 mm. Results are mean ± SEM from at least 3 independent experiments performed in duplicate. *p < 0.05 vs. respective controls (untreated cells).Frontiers in Pharmacology | www.frontiersin.org July 2020 | Volume 11 | Article 10126
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Mitochondrial-associated Nitric Oxide
Stress in 2DIV Cells, Though Upregulate
iNOS Gene Expression in Both Young and
Aged Microglia
Taking into account the activation profile induced by Bf and
because oxidative stress is a central regulator of HMGB1’s
translocation, release, and activity in inflammation and cell
death (Yu et al., 2015), we further assessed nitrosative stress-
related mediators in our model. As depicted in Figure 5A, aFrontiers in Pharmacology | www.frontiersin.org 7clear elevation of NO production was observed in 2DIV Bf-
treated microglia (p<0.05) with concentration-independent
levels. In contrast, the 16DIV cells showed a reduction
(p<0.05), which was again similar for 50 nM and 100 nM Bf.
Data reinforce the age-dependent response of microglia to these
concentrations of Bf in terms of NO production. However,
when we evaluated the mRNA gene expression of inducible
nitric oxide synthase (iNOS), we verified that both 2DIV and
16DIV exhibited elevated levels when treated with Bf 100 nM




FIGURE 3 | Activation of 2DIV microglia with free bilirubin (Bf) is associated with decreased CX3CR1 and increased HMGB1 levels, which are not observed in 16DIV
cells. Microglial cells were treated at 2 and 16 days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation, CX3CR1 (A) and HMGB1 (B) gene expression
was evaluated by Real Time-PCR, as specified in methods. HMGB1 protein detection was performed by immunocytochemistry using anti-HMGB1, as indicated in
methods. Representative results of one experiment are shown (C). Percentage of HMGB1 positive cells was performed using ImageJ software and applying a
threshold (D). Results are fold change (A, B) and mean percentage ± SEM (D) vs. respective control (untreated cells) from at least 4 independent experiments
performed in duplicate. *p < 0.05 and **p < 0.01 vs. respective controls.
Vaz et al. Young Microglia: A Risk to Bilirubin ToxicityiNOS in the same model and independently of the microglia age
in culture was obtained upon amyloid-b exposure (Ab)
(Caldeira et al., 2017).
To assess whether the NO release resulted from an increase in
microglial mitochondrial activity, we have used MitoTracker®
Red, a cell-permeant probe that enters in actively respiring cells,
where it is oxidized and sequestered in the mitochondria, reacting
with thiols of proteins/peptides and forming an aldehyde-fixable
conjugate. Higher staining densities of this probe was present in
2DIV cells treated with Bf 100 nM (p<0.05, Figures 5C, D), while
changes were absent in 16DIV cells, suggesting that only the
younger cells increase mitochondrial-related NO stress upon Bf
stimulation. Therefore, we may hypothesize that the elevation of
iNOS by an age-independent Bf stimulation can result from other
simultaneous intracellular activated signaling pathways not
involving mitochondria (Aktan, 2004).Upregulation of Transcriptional
Inflammatory Pathological Profiles Is a
Specific Feature of Bf-Treated Young
Microglia
Having observed that 2DIV microglia show a higher
susceptibility to activation by Bf than the long-maturated cells,
we next determined the differential expression of polarized-
specific genes in Bf-treated cells. In our previous studies the
use of genes associated with anti-inflammatory and pro-Frontiers in Pharmacology | www.frontiersin.org 8inflammatory microglia allowed the categorization of microglia
polarized state subpopulations (Silva et al., 2010; Silva et al.,
2011), including in the 2DIV/16DIV model here used (Caldeira
et al., 2014; Caldeira et al., 2017).
As shown in Figure 6, arginase 1 and IL-1b were equally
elevated in 2DIV and 16DIV microglia after treatment with Bf
(p<0.01 and p<0.05 in the first and p<0.01 in 2DIV cells, p<0.05 in
16DIV ones for the later, for both Bf concentrations). Also included
in the similar transcriptional profile induced by Bf-stimulation in
young and aged microglia is the decrease of the anti-inflammatory
IL-10 (p<0.05 for both Bf concentrations in the former and only for
Bf 100 nM in the later). However, the young activated microglia
were unique in additionally displaying upregulated transcriptional
profiles of MHCII, TNF-a and IL-6 (more than 10-fold),
supporting the increased proinflammatory population subtypes
generated by Bf stimulation in young cells relatively to the older
ones that revealed to be poor responders.
Though there is still an incomplete clarification of the role of
miRNAs in microglia, either in health or in neuropathological
conditions, the dysregulation of certain miRNAs, such as
inflamma-miRs, are known to contribute to abnormal cell
polarization, hyper-activation and persistent neuroinflammation
(Fernandes et al., 2018; Guo et al., 2019). Validating the Bf-
induced signature of the common inflammatory mediators
previously found in 2DIV microglia, almost all the assessed
inflamma-miRs were overexpressed in young cells, but
downregulated in the long-cultured microglia, independently ofA
B
FIGURE 4 | Free bilirubin (Bf) upregulates GLT-1 only in young microglia. Microglial cells were treated at 2 and 16 days-in-vitro (DIV) with 50 nM and 100 nM Bf for
24 h. After incubation, detection of GLT-1 levels was performed by immunocytochemistry using anti-GLT-1, as indicated in methods. Representative results from one
experiment are shown (A). Scale bar represents 40 mm. Quantification of the mean fluorescence intensity of GLT-1 in each cell was normalized to their total area (B).
For that, individual cells were manually traced using ImageJ software. Results are mean ± SEM fold change vs. respective controls (untreated cells) from at least 5
independent experiments performed in duplicate. *p < 0.05 vs. respective control.July 2020 | Volume 11 | Article 1012
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more involved in microglia inflammatory response, miR-155,
miR-146a, and miR-124 (Su et al., 2016), the first two were
upregulated in 2DIV microglia by Bf, while were depressed in
the 16DIVmicroglia, thus reinforcing the irresponsive character of
the aged microglia towards Bf. Relatively to the anti-inflammatory
miR-124, it was decreased in both, this time reflecting a common
deficient microglia reparative action upon Bf, independently of the
age in culture (Figure 7). Now, if we consider the additional
increase of miR-125b and miR-21 in the 2DIV Bf-treatedFrontiers in Pharmacology | www.frontiersin.org 9microglia, these results additionally suggest that both anti-
inflammatory and pro-inflammatory subtypes are produced by
Bf originating mixed activated populations.
Overall, our results point that the susceptibility of young/
activated microglia to Bf-induced inflammatory response may
associate to the damaging effects of hyperbilirubinemia during
the neurodevelopment period and may be implicated in poorer
outcomes of the prematurely born neonates, highlighting the





FIGURE 5 | High levels of free bilirubin (Bf) upregulate iNOS gene expression in the differently aged microglia, though mitochondrial-associated NO stress only
occurs in 2DIV cells. Microglial cells were treated at 2 and 16 days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation, NO levels (A) were assessed
by Griess reagent and iNOS mRNA (B) by Real Time-PCR. Mitochondria was stained with mitotracker red and representative results from one experiment are shown
(C). Fluorescence intensity values were obtained by using ImageJ software to define the integrated density (D). Results are mean± SEM fold change vs. respective
controls (untreated cells) from at least 4 independent experiments performed in duplicate *p < 0.05 and **p < 0.01 vs. respective controls.July 2020 | Volume 11 | Article 1012
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In a previous work, we developed an experimental method to
naturally age microglia after isolation from the cortex of neonatal
mice brains (Caldeira et al., 2014). We showed that these cells
presented markers of a reactive phenotype early in culture
(2DIV) and that such profile changed along time (until
16DIV) to a less responsive microglia showing senescence
biomarkers and miRNAs of a deactivated/irresponsive subtype.
More recently, we demonstrated that 16DIV microglia are
poorer responders to amyloid-beta (Ab) peptide stimulation,
when compared to 2DIV cells, showing reduced phagocytosis,
migration ability and inflamma-miR expression (Caldeira et al.,
2017). UCB/Bf have been associated to either anti-oxidant or
neurotoxic properties in nerve cells depending on their
concentrations (Doré and Snyder, 1999; Doré et al., 1999).
Moreover, a wide spectrum of neuropathological findings by Bf
in neonates and in experimental models have been documented
(Wennberg et al., 1979; Cashore, 1990; Ostrow et al., 2004; Brites,
2012; Cayabyab and Ramanathan, 2019). Age-dependent pattern
of susceptibilities to BIND have been successively also
demonstrated in neural cells and mice models (Falcão et al.,
2005; Falcão et al., 2006; Bortolussi et al., 2014). However, only
few studies addressed the harmful effects of UCB/Bf in microglia
function (Gordo et al., 2006; Silva et al., 2010), and none investigated
whether differences in young and adult/aged microglia to Bf insults
may account to the increased vulnerabilities of neonates to
hyperbilirubinemia. Thus, the present work was designed to
evaluate the response of young vs. aged microglia to Bf stimulus
at concentrations mimicking moderate to high increased associated
risks. The data presented here support the concept that Bf induces
differential transcriptional profiles in short- and long-cultured
microglia (young/aged cells) with a predominant activation and
inflammatory profile manifested by the young microglia.
Modification of microglial morphology is one of the
hallmarks of cell activation and polarization (Chew et al., 2006;
Lynch, 2009). For that reason, we started by assessing the
morphological features of microglial cells upon Bf incubation.
Our first results based on Iba1 staining indicate that microglia
are preferentially activated by Bf at 2DIV, as compared with
16DIV cultures, with an increased number of cells with an
amoeboid shape, as well as increased CD11b stainning. Similar
profiles were obtained in microglia isolated fromWistar rats at 1-
to 2-day-old and treated with elevated concentrations of UCB
(Silva et al., 2010) and in the Gunn rat, a model of bilirubin
encephalopathy (Liaury et al., 2012). Rather than the originally-
perceived all or-none response, it is now accepted that microglia
are plastic cells adopting diverse phenotypes when activated (Luo
and Chen, 2012). Considering that the ramified morphology is
characteristic of surveillant microglia, while the amoeboid shape
predominates in the activated-state (Graeber, 2010), our results
show an increased number of activated cells by Bf among the
young cultured microglia population. Increased susceptibility of
young/immature astrocytes and neuronal cells to UCB, as
compared to maturated cells, was previously evidenced (Falcão
et al., 2005; Falcão et al., 2006). Early apoptosis was mainly
produced in young cells while late apoptosis/necrosis wasA
B
FIGURE 6 | Young microglia treated with high levels of free bilirubin (Bf) show
a prevalent upregulation of transcriptional inflammatory mediators, which are
marginally exhibited by 16DIV cells. Microglial cells were treated at 2 and 16
days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation,
mRNA expression of MHCII, Arginase 1 (Arg1), TNF-a, IL-1b, IL-6, and IL-10
was determined by Real Time-PCR in 2 DIV (A) and 16 DIV (B) cells. Results
are mean± SEM fold change vs. respective controls (untreated cells) from at
least 5 independent experiments performed in duplicate. *p < 0.05 and **p <
0.01 vs. respective controls.A
B
FIGURE 7 | Young microglia treated with high levels of free bilirubin (Bf) show
upregulation of miRNAs that mediate neuroinflammation, an effect inversely
sensed by the long-maturated cells. Microglial cells were treated at 2 and 16
days-in-vitro (DIV) with 50 nM and 100 nM Bf for 24 h. After incubation,
expression of miR-155/-125b/-21/-146a/124 was determined by Real Time-
PCR, either in 2 DIV (A) or 16 DIV (B) cells. Results are mean± SEM fold
change vs. respective controls (untreated cells) from at least 5 independent
experiments performed in duplicate. *p < 0.05 and **p < 0.01 and vs.
respective controls.July 2020 | Volume 11 | Article 1012
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negative and positive factors in age-associated cell dysfunction
(Tower, 2015). Such findings strongly suggest that Bf-induced
toxicity develops near (50 nM) or slight above (100 nM) the
aqueous saturation limit of 70 nM, a range in which UCB
monomers, oligomers, and metastable small colloids are likely
present (Ostrow et al., 2003). When we further characterized the
expression of cell markers associated to microglia differential
polarized states, we observed a decrease of the cell “calming”
signal CX3CR1 in the 2DIV microglia, probably accounting for
their preferential activated profile upon Bf interaction. CX3CR1-
deficient activated microglia were previously associated to
increased phagocytosis (Lee et al., 2010), deficient synaptic
integration and emotional behavioral alterations in mice (Bolos
et al., 2018), as well as to impaired cognitive function via
increased IL-1b (Rogers et al., 2011). Excessive microglia
phagocytosis of synapses and neurons is implicated in diverse
pathological processes (Vilalta and Brown, 2018). Once
CX3CL1-CX3CR1 axis is an important pathway to promote
synaptic plasticity processes (Sheridan and Murphy, 2013), the
increased levels of microglia CX3CR1 only in 16DIV after Bf
exposure may reflect an adaptive cell response to promote
neuronal-microglial communication. Nevertheless, elevated levels
of CX3CR1 and BDNF in microglia were also associated with
autism spectrum disorders (Edmonson et al., 2014). In fact, both
protective and detrimental effects have been reported for CX3CR1
deletion (Gyoneva et al., 2019) and the consequences of low and
high CX3CR1 expression in 2DIV and 16DIV Bf-treated microglia
should be later explored in co-cultures of neurons and microglia.
The microglial “alarming” signal HMGB1 is known to function
as a proinflammatory cytokine and to cause neurodegeneration,
being suggested as a therapeutic target (Paudel et al., 2018).
Actually, HMGB1 released from inflamed microglia was shown
to bind to Mac1 (macrophage antigen complex 1) and activate the
NF-kB pathway, as well as the NADPH oxidase, thus stimulating
the production of multiple inflammatory and neurotoxic factors
(Gao et al., 2011). Considering the association of HMGB1 with
such neuroinflammatory events we anticipated its upregulation
mainly in the young Bf-treated microglia. Indeed, we observed
increased transcriptional profile, higher levels of cytoplasmatic
HMGB1 and enhanced HMGB1-positive cells in 2DIV Bf-treated
microglia, but no changes in aged ones. Such profile agrees with
previous studies showing that HMGB1 and the downstream
cellular inflammatory response are enhanced in young, relatively
to adult or old mice (Prasad and Thakur, 1990; Webster et al.,
2019). Due to its role in sustaining inflammation and causing
chronic neurodegeneration (Mittal et al., 2014), as well as in
mediating the process of fetal and neonatal tissue injury
(Buhimschi et al., 2009), HMGB1 targeting may reveal a
promising therapeutic strategy to prevent BIND and outcomes
beyond the inflammatory response in neonates.
During the neuroinflammatory process, microglia release
glutamate that causes excitotoxicity and exacerbates neurotoxicity
(Barger et al., 2007), but also participate in its uptake by expressing
different types of glutamate transporters (Kettenmann et al., 2011),
as is the case of GLT-1 that is upregulated in activated microgliaFrontiers in Pharmacology | www.frontiersin.org 11(Lopez-Redondo et al., 2000; Persson et al., 2005). Release of
substantial levels of glutamate from microglia in response to
bilirubin was previously demonstrated (Gordo et al., 2006; Silva
et al., 2010). Here, GLT-1 increase only occurred in the young/
immature Bf-treated microglia suggesting a protective intervention
against the Bf stimulus on glutamate release (Fernandes et al., 2004;
Gordo et al., 2006). Actually, UCB-induced release of glutamate is
higher in young than in old nerve cells (Falcão et al., 2006) and may
relate with the increased levels of HMGB1, which are known to
stimulate the glutamate release in mice synaptosomes and astrocytic
gliosomes (Pedrazzi et al., 2006).
In earlier studies we have demonstrated that UCB induces
nNOS expression and NO production in immature rat neurons
cultured for 3DIV (Vaz et al., 2011b), while also causes NO
production by activated microglia in organotypic hippocampal
slices from 7- to 10-day-old Wistar rats (Silva et al., 2012).
In this study, we showed that Bf at 100 nM upregulates iNOS
gene expression in both young and aged cultured cortical mouse
microglia. Overexpression of iNOS was found in amoeboid
microglia in developing retina, while downregulated levels were
observed in ramifiedmicroglia (Sierra et al., 2014). Several signalling
cascades determine the expression of iNOS in glial cells, whose
elevated levels are observed during neuroinflammation in
neurodegenerative disorders (Saha and Pahan, 2006). Our data
show that Bf produces a wide variety of proinflammatory and
degenerative stimuli mainly in the young microglia and, therefore,
iNOS upregulation may result from Bf direct immunostimulation.
On the other hand, iNOS increase in 16DIV cells can be related with
an enhanced IL-1b-induced iNOS due to microglia alterations by
aging (Norden and Godbout, 2013), as the enhanced late apoptosis/
necrosis suggest in these cells. However, just the 2DIV Bf-treated
cells led to NO generation by either one of the tested concentrations,
since the 16DIV microglia contrasted by the reduced production of
NO. Thus, mitochondria nitrosative-induced stress was just
observed in young microglia and by the Bf highest level. Actually
mitochondria has been pointed as a target of BIND (Brites, 2012)
and mitochondrial depolarization and impairment of the
respiratory chain previously reported in UCB-treated immature
neurons (Vaz et al., 2010).
Originally, it was accepted that microglia activation resulted in
two main phenotypes, a proinflammatory M1 subtype and an anti-
inflammatory and reparative subtype M2, though more recent
studies showed that M1 and M2 are not isolated phenomena
(Ransohoff, 2016) and that multiple microglia phenotypic markers
may co-exist (Torres-Platas et al., 2014). Evidences show that
microglia can switch phenotypes and differentially express gene
signatures in response to a variety of insults, either using microglial
cell lines or primary cultures from mice modeling amyotrophic
lateral sclerosis (ALS) and Alzheimer’s disease (AD) (Caldeira et al.,
2017; Pinto et al., 2017; Vaz et al., 2019). Here, we demonstrate that
Bf increases the expression of mRNA levels of MHCII, TNF-a, IL-
1b, and IL-6 inflammatory mediators in 2DIV microglia, from
which only IL-1b was found elevated in 16DIV cells. These findings
point to a predominant switch of young microglia to a pro-
inflammatory phenotype by Bf, while it only scarcely activated the
aged cells. Reinforcing the pro-inflammatory stimulus of Bf,July 2020 | Volume 11 | Article 1012
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critical role in immunoregulation (Saxena et al., 2015; Ip et al.,
2017), was present in both cell aged types. In short, microglia may
be primed by Bf during neonatal hyperbilirubinemia leading to
neurodevelopmental critical outcomes and increased susceptibilities
to cognitive deficits by a secondary inflammatory insult in later life
(Hoeijmakers et al., 2016; Paolicelli and Ferretti, 2017). To the best
of our knowledge, this the first study showing that immature/
neonatal microglia have an increased vulnerability to the pro-
inflammatory effects of elevated concentrations of Bf. The
slow response of the 16DIV maturated microglia to Bf
immunostimulation may be associated to an acquired senescent-
like phenotype (Caldeira et al., 2014) that was later demonstrated to
be irresponsive to Ab insult (Caldeira et al., 2017). Interestingly, as
here reported, elevation of IL-1b was produced in 2DIV and 16DIV
microglia upon Ab incubation. Besides its role as a proinflammatory
cytokine, IL-1b also belongs to the senescent-associated secretory
phenotype (SASP) proteins (Ozcan et al., 2016). Thus, we
hypothesize that the increased IL-1b mRNA levels in long
maturated cells exposed to Bf may derive from the cell ageing,
instead of being exclusively linked to a pro-inflammatory state. Up-
regulation of arginase 1, mainly associated with the resolution of
damage and associated with a neuroprotective profile (Colton, 2009)
was similarly observed in cells cultured for short or long time afterFrontiers in Pharmacology | www.frontiersin.org 12Bf treatment. Indeed, compensatory immune-inflammatory
responses to UCB have been proposed in patients with bilirubin
encephalopathy, where certain bioactive proteins, including
defensins (e.g. a- defensin 1, DEFA1) and/or alarmins (e.g.
C−reactive protein, S100A7 or S100A9) were differentially up/-
down-regulated in extracellular vesicles isolated from the
cerebrospinal fluid of those patients (Tan et al., 2020). Nevertheless,
arginase 1 was also shown to support the inflammatory state in some
studies (Abad Dar and Holscher, 2018) and to be upregulated by LPS
in others (Zhang et al., 2009). To additionally refer that upregulation
of arginase 1 in both 2DIV and 16DIV microglia was observed upon
Ab incubation, as well (Caldeira et al., 2017).
Considering the key roles of microglia in neurogenesis and
developmental synaptic pruning, as well as their trophic
support (Cowan and Petri, 2018), the early-life induced
inflammation by Bf may have immediate and lasting
consequences. Despite knowledge about miRNAs in
neuroinflammation (Karthikeyan et al., 2016), little is known
on their role in microglia inflammatory responses and
mediated pathologies, though their dysregulation has been
associated to perinatal brain injury (Cho et al., 2019). To
date, no study has explored if and how inflamma-miRs are
dysregulated in microglia activated by bilirubin, and whether
the signature differs according to cell maturation. We assessedFIGURE 8 | Schematic representation of microglia response to free bilirubin (Bf), considering young and aged cultured cells. Microglial cells were treated at 2
(young) and 16 days-in-vitro (DIV) (aged) with 50 nM and 100 nM Bf for 24 h. Results show that short-cultured 2DIV microglia are more reactive to Bf than the long-
cultured 16DIV cells. In young cells, both Bf concentrations favour Iba-1 amoeboid microglia and cause ~1.5-fold increase in CD11b-positive cells over aged
microglia. Low levels of CX3CR1 and increased values of the alarmin HMGB1 in Bf-treated young cells, not exhibited by the aged cells, reinforce their proneness to
Bf stimulation, a finding also reproduced by GLT-1 upregulation. Bf-induced mitochondrial-nitrosative stress (increased levels of either iNOS and NO) is again more
notorious in 2DIV cells. These young microglia reveal to be unique in overexpressing inflammatory-associated markers upon Bf interaction (MHCII/TNF-a/IL1b/IL-6),
apart arginase 1 (Arg1) and IL-1b that also increase in aged cells. The immunostimulant effect of Bf in the neonatal-like microglia and their increased reactivity to the
injury is translated in the elevation of most of the inflammatory-associated miRNAs in 2DIV cells (miR-155/-125b/-21/-146a), while a depressed signature is found in
the aged microglia. However, a common finding in the differently aged microglia by Bf interaction was the reduction of the “calming” IL-10 and miR-124 mediators in
both, thus indicating the presence of shared immune responses. In sum, immune activation by Bf is more robust in early-life microglia and may increasingly impact
on neonatal illness by hyperbilirubinemia, thus requiring immunoregulatory approaches to prevent clinical deterioration and related neurodevelopmental disabilities.July 2020 | Volume 11 | Article 1012
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of the immunoregulatory microglial functions (Fernandes et al.,
2018; Vaz et al., 2019), namely miR-155, miR-146a, miR-125b,
miR-124, and miR-21. Validating the Bf-immunostimulant effect
on young microglia pro-inflammatory state, all miRNAs were
found upregulated except miR-124 that mitigates microglia-
induced neuroinflammation (Yu et al., 2017). From these miR-
155 was shown to induce a pro-inflammatory response and to be
early upregulated in the triple transgenic AD mouse model, while
miR-124 acts as a negative regulator (Ponomarev et al., 2011;
Guedes et al., 2014; He et al., 2014). Attesting the heterogeneity of
activated microglia phenotypes by Bf in 2DIV cells, the
overexpression of miR-21 and miR-146a shows that microglia
may also induce the production of these inflammatory regulators
(Wang et al., 2018) subsequently to Bf-induced microglial
immunostimulation and upregulation of miR-155. Another
important fine tuner of inflammation is miR-125b related to
microglia activation in ALS (Parisi et al., 2016). As a curiosity,
in obstructive jaundice, miR-21 and miR-125b, among others,
were found upregulated in the mouse liver (Kanda et al., 2010)
and the later associated with increased tau hyperphosphorylation
(Banzhaf-Strathmann et al., 2014; Zhang et al., 2019). Again,
exposure to bilirubin early in life in newborn rats was suggested to
promote AD-like pathological changes later in life, including tau
protein hyperphosphorylation, Ab production and spatial
learning and memory injuries (Chen et al., 2019), pointing to
the significance of microglial priming in jaundiced infants during
the neonatal period.
In contrast with the early activation of cortical microglia by Bf
concentrations of 50 nM and 100 nM, decrease of miR-155, miR-
146a, and miR-124, the three miRNAs most recognized as being
involved in microglia inflammatory responses (Su et al., 2016), in
the aged cells highlight either a senescence-like cell behaviour and
irresponsiveness to Bf stimulus, or alternatively an adaptive
response to counteract the inflammatory stimulus (Tili et al.,
2007; Caldeira et al., 2014; Parisi et al., 2016; Caldeira et al., 2017).
In conclusion, this study adds to our understanding on how Bf
can affect microglia dynamic properties, and support the
vulnerability of the young cells, which turn overactivated even at
moderated levels of Bf, as schematically represented in Figure 8.
The susceptibility of newborns and their immature nerve cells to
BIND, together with the deregulation of microglial immune
response by Bf with early and ensuing impacts in degenerative
processes, suggest immunomodulation as a promising therapeutic
strategy in neonates in risk for bilirubin encephalopathy and
critical outcomes.Frontiers in Pharmacology | www.frontiersin.org 13DATA AVAILABILITY STATEMENT
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Doré, S., and Snyder, S. H. (1999). Neuroprotective action of bilirubin against
oxidative stress in primary hippocampal cultures. Ann. N. Y. Acad. Sci. 890,
167–172. doi: 10.1111/j.1749-6632.1999.tb07991.x
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